Sahithi Pharma Profile
Key Indicators
- Authorised Capital ₹ 11.50 Cr
as on 05-11-2024
- Paid Up Capital ₹ 11.50 Cr
as on 05-11-2024
- Company Age 3 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 21.25 Cr
as on 05-11-2024
- Revenue 57.66%
(FY 2023)
- Profit -38.01%
(FY 2023)
- Ebitda 20.47%
(FY 2023)
- Net Worth 15.14%
(FY 2023)
- Total Assets 8.44%
(FY 2023)
About Sahithi Pharma
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 11.50 Cr and a paid-up capital of Rs 11.50 Cr.
The company currently has active open charges totaling ₹21.25 Cr.
Nagaraju Nadimpally, Anjaneya Penmetsa, and Sridhar Gadiraju serve as directors at the Company.
- CIN/LLPIN
U24110TG2021PTC151302
- Company No.
151302
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 May 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
K.V.Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sahithi Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nagaraju Nadimpally  | Director | 11-May-2021 | Current |
| Anjaneya Penmetsa | Director | 11-May-2021 | Current |
| Sridhar Gadiraju | Director | 11-May-2021 | Current |
Financial Performance of Sahithi Pharma.
Sahithi Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 57.66% increase. The company also saw a substantial fall in profitability, with a 38.01% decrease in profit. The company's net worth Soared by an impressive increase of 15.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sahithi Pharma?
In 2023, Sahithi Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 22 Sep 2021 | ₹12.75 Cr | Open |
Others Creation Date: 22 Sep 2021 | ₹8.50 Cr | Open |
How Many Employees Work at Sahithi Pharma?
Sahithi Pharma has a workforce of 0 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sahithi Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sahithi Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
